SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Philips CA, Paramaguru R, Augustine P. BMJ Case Rep. 2018; 2018: e225590.

Affiliation

The Liver Unit, Cochin Gastroenterology Group, Ernakulam Medical Centre, Kochi, Kerala, India.

Copyright

(Copyright © 2018, BMJ Publishing Group)

DOI

10.1136/bcr-2018-225590

PMID

29960971

Abstract

Ayurveda Bhasma is a metallic-mineral preparation homogenised with herbal juices or decoctions and modified with heat treatment to apparently detoxify the heavy metals. It is widely recommended for the treatment of many disease conditions by practitioners of complementary and alternative medicine in the absence of good quality clinical trial evidence on its safety and efficacy. Heavy metal-induced liver injury is widely reported in the literature, and heavy metal adulteration of non-Bhasma-related Ayurveda and herbal products has been well described. We report a patient who developed severe liver injury requiring listing for liver transplantation for improved survival, after consumption of Bhasma for dyspepsia. This case describes the first documented case and toxicology analysis of Ayurveda Bhasma associated with severe drug-induced liver injury. Physicians must be alert regarding patient's use of supposedly safe Ayurveda Bhasma that may promote acute severe liver injury in the absence of other known aetiologies.

© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.


Language: en

Keywords

complementary medicine; drugs: gastrointestinal system; healthcare improvement and patient safety; liver disease; toxicology

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print